Abstract:OBJECTIVE:Portal vein metastasis of hepatocellular carcinoma (HCC) results in a poor prognosis and seriously affects the survival rate of patients. The mechanism underlying the formation of portal vein tumor thrombus (PVTT) is complex and is not yet fully understood. This study was conducted to investigate the impact of portal vein blood on the proliferation, metastasis, invasion and apoptosis of PVTT cells and to explore its possible mechanisms, which was expected to lay a foundation for ascertaining the mechanism underlying the portal vein metastasis of HCC. METHODS:Peripheral blood and portal vein blood were collected from patients with HCC, and the sera from these two sources were used to culture the PVTT-originated HCC cell line CSQT-2. The cells were collected after 24 h, and flow cytometry was performed to detect cell proliferation, cell cycle stages and apoptosis. Transwell migration and invasion assays were applied to detect the metastasis and invasion of the cells in each group. The changes in the expression of MMP-2 and MMP-9 in cells were detected via Western blotting. The contents of IL-12, IFN-γ, IL-1β, IL-2 and TNF-α in the two groups of sera were quantified using corresponding kits. RESULTS:Compared with the group of cells cultured with peripheral serum, the cells cultured with portal vein serum showed significantly lower apoptosis (P<0.01), significantly enhanced cell metastasis and invasion (P<0.01), whereas cell proliferation and the stages of the cell cycle did not differ significantly (P>0.05). A significantly increased expression level of MMP-2 has been observed in tumor cells treated portal vein serum. In addition, compared with peripheral serum, the content of IL-12 was significantly decreased in portal vein serum (P<0.05), while the contents of IFN-γ, IL-1β, IL-2, and TNF-α did not differ significantly (P>0.05). CONCLUSIONS:Portal vein serum from HCC patients could inhibit the apoptosis of PVTT-originated HCC cells and promote cell metastasis and invasion. This effect may be related to the lower level of IL-12 in portal vein serum.

Research progress on the formation mechanism of hepatocellular carcinoma with portal vein tumor thrombus

Research Progress on Mechanisms of Hepatic Portal Vein Tumor Thrombus Formation

Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma

Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

The Progress in Diagnosis and Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Recent Advances on the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Portal Vein Tumor Thrombus is a Bottleneck in the Treatment of Hepatocellular Carcinoma

Advances in the Treatment of Hepatocellular Carcinoma Combined with Hepatic Vein Tumor Thrombus

Research advances in liver cirrhosis complicated by portal vein thrombosis

Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma

Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.

Bottleneck and strategies in the treatment of hepatocellular carcinoma with portal vein tumor thrombus

Updates of diagnosis and differential diagnosis for hepatocellular carcinoma with portal vein tumor thrombus

Advances in Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

Role of Platelets in the Malignant Progression of Hepatocellular Carcinoma

Experimental Study on Enhancement of the Metastatic Potential of Portal Vein Tumor Thrombus-Originated Hepatocellular Carcinoma Cells Using Portal Vein Serum.

The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma